Charles Schwab’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Buy |
1,461,177
+720
| +0% | +$6.86K | ﹤0.01% | 2001 |
|
|
2025
Q4 | $17.7M | Buy |
1,460,457
+336,354
| +30% | +$4.09M | ﹤0.01% | 1829 |
|
|
2025
Q3 | $13.1M | Buy |
1,124,103
+28,648
| +3% | +$343K | ﹤0.01% | 1975 |
|
|
2025
Q2 | $10.2M | Sell |
1,095,455
-17,338
| -2% | -$136K | ﹤0.01% | 2006 |
|
|
2025
Q1 | $8.16M | Sell |
1,112,793
-18,692
| -2% | -$144K | ﹤0.01% | 2049 |
|
|
2024
Q4 | $9.66M | Buy |
1,131,485
+21,025
| +2% | +$205K | ﹤0.01% | 2028 |
|
|
2024
Q3 | $9.66M | Buy |
1,110,460
+660,080
| +147% | +$5.44M | ﹤0.01% | 2039 |
|
|
2024
Q2 | $3.08M | Buy |
450,380
+137,344
| +44% | +$848K | ﹤0.01% | 2552 |
|
|
2024
Q1 | $2.85M | Buy |
313,036
+91,834
| +42% | +$652K | ﹤0.01% | 2489 |
|
|
2023
Q4 | $987K | Buy |
221,202
+6,787
| +3% | +$20.1K | ﹤0.01% | 2837 |
|
|
2023
Q3 | $673K | Hold |
214,415
| – | – | ﹤0.01% | 2937 |
|
|
2023
Q2 | $1.11M | Buy |
214,415
+8,166
| +4% | +$48.6K | ﹤0.01% | 2737 |
|
|
2023
Q1 | $1.09M | Buy |
206,249
+1,720
| +0.8% | +$8.17K | ﹤0.01% | 2707 |
|
|
2022
Q4 | $575K | Buy |
204,529
+3,742
| +2% | +$12.4K | ﹤0.01% | 2961 |
|
|
2022
Q3 | $834K | Buy |
200,787
+418
| +0.2% | +$2.1K | ﹤0.01% | 2845 |
|
|
2022
Q2 | $806K | Sell |
200,369
-698
| -0.3% | -$2.64K | ﹤0.01% | 2876 |
|
|
2022
Q1 | $996K | Buy |
201,067
+7,974
| +4% | +$44.2K | ﹤0.01% | 2848 |
|
|
2021
Q4 | $1.35M | Sell |
193,093
-57,748
| -23% | -$448K | ﹤0.01% | 2804 |
|
|
2021
Q3 | $2.51M | Buy |
250,841
+1,416
| +0.6% | +$15.9K | ﹤0.01% | 2648 |
|
|
2021
Q2 | $3.54M | Buy |
249,425
+7,128
| +3% | +$108K | ﹤0.01% | 2515 |
|
|
2021
Q1 | $3.98M | Buy |
242,297
+73,657
| +44% | +$1.42M | ﹤0.01% | 2400 |
|
|
2020
Q4 | $3.49M | Buy |
168,640
+21,150
| +14% | +$314K | ﹤0.01% | 2389 |
|
|
2020
Q3 | $1.12M | Buy |
147,490
+15,043
| +11% | +$125K | ﹤0.01% | 2648 |
|
|
2020
Q2 | $1.1M | Buy |
132,447
+21,825
| +20% | +$145K | ﹤0.01% | 2595 |
|
|
2020
Q1 | $548K | Sell |
110,622
-4,133
| -4% | -$20.4K | ﹤0.01% | 2681 |
|
|
2019
Q4 | $454K | Buy |
114,755
+5,720
| +5% | +$19.9K | ﹤0.01% | 2855 |
|
|
2019
Q3 | $332K | Buy |
109,035
+8,377
| +8% | +$37.4K | ﹤0.01% | 2945 |
|
|
2019
Q2 | $443K | Buy |
100,658
+27,585
| +38% | +$102K | ﹤0.01% | 2864 |
|
|
2019
Q1 | $291K | Buy |
73,073
+514
| +0.7% | +$2.07K | ﹤0.01% | 2947 |
|
|
2018
Q4 | $289K | Hold |
72,559
| – | – | ﹤0.01% | 2948 |
|
|
2018
Q3 | $500K | Hold |
72,559
| – | – | ﹤0.01% | 2840 |
|
|
2018
Q2 | $490K | Buy |
72,559
+18,989
| +35% | +$130K | ﹤0.01% | 2811 |
|
|
2018
Q1 | $349K | Buy |
53,570
+15,100
| +39% | +$85K | ﹤0.01% | 2833 |
|
|
2017
Q4 | $172K | Hold |
38,470
| – | – | ﹤0.01% | 3003 |
|
|
2017
Q3 | $238K | Hold |
38,470
| – | – | ﹤0.01% | 2960 |
|
|
2017
Q2 | $357K | Hold |
38,470
| – | – | ﹤0.01% | 2804 |
|
|
2017
Q1 | $358K | Hold |
38,470
| – | – | ﹤0.01% | 2764 |
|
|
2016
Q4 | $322K | Buy |
38,470
+19,900
| +107% | +$154K | ﹤0.01% | 2822 |
|
|
2016
Q3 | $128K | Hold |
18,570
| – | – | ﹤0.01% | 2991 |
|
|
2016
Q2 | $92K | Hold |
18,570
| – | – | ﹤0.01% | 3061 |
|
|
2016
Q1 | $180K | Hold |
18,570
| – | – | ﹤0.01% | 2920 |
|
|
2015
Q4 | $175K | Hold |
18,570
| – | – | ﹤0.01% | 2986 |
|
|
2015
Q3 | $262K | Hold |
18,570
| – | – | ﹤0.01% | 2877 |
|
|
2015
Q2 | $391K | Buy |
18,570
+10,270
| +124% | +$254K | ﹤0.01% | 2772 |
|
|
2015
Q1 | $349K | Buy |
+8,300
| New | +$273K | ﹤0.01% | 2776 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
